| Daisy Perez, RPH | |
|
Carr 2 Inter Calle Baramaya, 2643 Ponce By Pass, Ponce, PR 00728 | |
| (787) 812-1616 | |
| (787) 812-1625 |
| Full Name | Daisy Perez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Carr 2 Inter Calle Baramaya, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093935165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4319 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daisy Perez, RPH Carr 2 Inter Calle Baramaya, 2643 Ponce By Pass, Ponce, PR 00728 Ph: (787) 812-1616 | Daisy Perez, RPH Carr 2 Inter Calle Baramaya, 2643 Ponce By Pass, Ponce, PR 00728 Ph: (787) 812-1616 |
News Archive
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
Akebia Therapeutics, Inc., a small molecule discovery and development company focused on anemia and vascular disorders, today announced that it has dosed the first subjects in a first-in-man Phase 1 study of AKB-9778, a first-in-class human protein tyrosine phosphatase beta (HPTPβ) inhibitor in development for diabetic macular edema (DME) and diabetic retinopathy (DR).
JumpStart Ventures, which invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in drug development company ChanRx. The two-year-old company is developing a pharmaceutical compound to treat atrial fibrillation, a heart condition that affects two million Americans, with 200,000 new cases being diagnosed each year.
› Verified 8 days ago
Sindy Candelario Gonzalez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Paseo Del Veterano, Ponce, PR 00716 Phone: 787-641-7582 Fax: 787-651-4317 | |
Dr. Michael John Borrero-marrero, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2706 Ave Maruca, Ponce, PR 00728 Phone: 787-812-5978 | |
Coral Marie Costas, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2023 Las Americas Ave., Ponce, PR 00717 Phone: 787-843-5710 | |
Edda Franceschini, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 65 Calle Estrella, Ponce, PR 00730 Phone: 787-848-3137 Fax: 787-840-6179 | |
Jessica Santiago Burgos, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2706 Ave Maruca, Df02565-0, Ponce, PR 00728 Phone: 787-812-5978 | |
Dexter Javier Hoyos, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 553 Calle Ramos Antonini, Ponce, PR 00728 Phone: 787-844-2805 Fax: 787-841-5551 | |
Mrs. Jessie Aslyn Suarez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2023 Ave Las Americas, Walgreens Store 199, Ponce, PR 00731 Phone: 787-843-5777 Fax: 787-843-3547 |